Printed 04 December 2017
NeuroPace, a Plastic Valley-based medical technology company that developed closed-loop brain-responsive neurostimulation system for epilepsy, has launched new RNS Tablet, a cutting-edge method for clinicians to examine their patients’ electrocorticographic (ECoG) data and personalize therapy.
Named is going to be displayed and readily available for use during hands-on workshops in the American Epilepsy Society’s (AES) Annual Meeting in Washington D.C. from December 1-5 at booth 1101.
“Since its beginning, the RNS System provides physicians unparalleled use of details about their patients’ brain activity,” stated NeuroPace Chief executive officer Frank Fischer.
“The RNS Tablet provides faster use of these details using the data presented in formats which are easily understandable and actionable by physicians. As an effect, physicians can optimize patient therapy more proficiently.Inches
The RNS Tablet was created together with clinicians to supply a simpler, smarter, and faster consumer experience. Product enhancements allow clinicians to examine and evaluate data more rapidly, garner a much deeper knowledge of their patients’ brain activity, while increasing clinical workflow efficiency.
“Having use of patient data inside a centralized, easy-to-use interface is invaluable when monitoring patient progress and personalizing therapy,” states Dr. Vikram Rao, Epileptologist at UCSF Clinic.
Named, which boasts an intuitive touchscreen and color interface that instantly connects to the web, also features:
Simpler: A built-in, wireless platform that mixes the standard NeuroPace Programmer an internet-based Patient Data Management System (PDMS) right into a singular interface.
Smarter: An interactive, customizable visual histogram that displays trends in neurostimulator and ECoG data to allow significant insights.
Faster: Various upgrades that decrease the amount of clicks required to program, including the opportunity to copy stimulation settings to any or all five treatments with a single click.
The RNS Product is the world’s first and just closed-loop brain-responsive neurostimulation system made to prevent epileptic seizures in their source. The RNS System treats seizures by continuously monitoring brain waves, discovering unusual activity, and instantly responding with imperceptible electrical pulses before seizures occur.
Physicians can program the recognition and stimulation parameters from the implanted RNS neurostimulator to personalize therapy for everybody. The RNS® Product is an adjunctive therapy for adults with refractory, partial onset seizures with a maximum of 2 epileptogenic foci.
Source: Company Pr Release